Results 171 to 180 of about 2,451,911 (303)

Plate-Counting Techniques for Average Bioburden Below the Limit of Detection. [PDF]

Biomed Instrum Technol
Brydon N.
europepmc   +1 more source

Characterizing a New Fluorescent Protein for a Low Limit of Detection Sensing in the Cell-Free System. [PDF]

ACS Synth Biol, 2022
Copeland CE, Kim J, Copeland PL, Heitmeier CJ, Kwon YC.   +4 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Improving accuracy in genome-wide association studies: a two-step approach for handling below limit of detection biomarker measurements. [PDF]

NAR Genom Bioinform
Deng YA, Karlsson T, Johansson Å.
europepmc   +1 more source

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens. [PDF]

Pathogens, 2023
Nielsen MC, Clarner P, Paroha R, Lee S, Thwe PM, Ren P.   +5 more
europepmc   +1 more source

Detecting and reporting the limits of rTMS

Clinical Neurophysiology, 2022
openaire   +3 more sources

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Signal Perception in Two-Dimensional Mapping Techniques: Just Noticeable Difference as a Visual Limit of Detection. [PDF]

Anal Chem
Cernatič F, Brunnbauer L, Mervič K, Willner J, Limbeck A, Šala M.   +5 more
europepmc   +1 more source

Nanoplasmonic NO₂ Sensor with a Sub-10 Parts per Billion Limit of Detection in Urban Air. [PDF]

ACS Sens, 2022
Tanyeli I, Darmadi I, Sech M, Tiburski C, Fritzsche J, Andersson O, Langhammer C.   +6 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source